PR was more frequently observed in the group of patients bearing a cancer with a high proportion of BECLIN 1-positive tumour cells than in the group of patients bearing a BECLIN-negative cancer (25% versus 15%), and DOD was also less frequent in the former than in the latter group of patients (17% versus 45%). This evidence concerns the gene BECN1 and cancer.